Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies-Reference-Cited by-同舟云学术

Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies

Published:2024-01-31 Issue:1 Volume:35 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Simpson Eric L.¹,Bissonnette Robert²,Chiesa Fuxench Zelma C.³,Kallender Howard⁴,Sturm Daniel⁴,Ren Haobo⁴,Stein Gold Linda F.⁵

Affiliation:

1. Department of Dermatology, Oregon Health & Science University, Portland, OR, USA

2. Innovaderm Research, Montreal, Quebec, Canada

3. Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA

4. Incyte Corporation, Wilmington, DE, USA

5. Henry Ford Health System, Detroit, MI, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2024.2310633

Reference30 articles.

1. Atopic dermatitis

2. Distribution of atopic dermatitis lesions in United States adults

3. Head-and-neck dermatitis: Diagnostic difficulties and management pearls

4. Impact of Atopic Dermatitis Lesion Location on Quality of Life in Adult Patients in a Real-world Study

5. Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fungal Head and Neck Dermatitis: Current Understanding and Management;Clinical Reviews in Allergy & Immunology;2024-07-20